BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32075271)

  • 21. Highly Pathogenic Avian H7N9 Influenza Viruses: Recent Challenges.
    Ma MJ; Yang Y; Fang LQ
    Trends Microbiol; 2019 Feb; 27(2):93-95. PubMed ID: 30553653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
    Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A(H7N9) virus in guinea pigs.
    Park S; Lee I; Kim JI; Bae JY; Yoo K; Kim J; Nam M; Park M; Yun SH; Cho WI; Kim YS; Ko YY; Park MS
    Biochem Biophys Res Commun; 2016 Oct; 479(2):192-197. PubMed ID: 27613087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PB2 mutation with lysine at 627 enhances the pathogenicity of avian influenza (H7N9) virus which belongs to a non-zoonotic lineage.
    Li W; Lee HHY; Li RF; Zhu HM; Yi G; Peiris JSM; Yang ZF; Mok CKP
    Sci Rep; 2017 May; 7(1):2352. PubMed ID: 28539661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication.
    Wolf S; Wu W; Jones C; Perwitasari O; Mahalingam S; Tripp RA
    PLoS One; 2016; 11(5):e0155104. PubMed ID: 27166678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular transcripts regulated during infections with Highly Pathogenic H5N1 Avian Influenza virus in 3 host systems.
    Balasubramaniam VR; Hassan SS; Omar AR; Mohamed M; Noor SM; Mohamed R; Othman I
    Virol J; 2011 Apr; 8():196. PubMed ID: 21529348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin.
    Xu Y; Peng R; Zhang W; Qi J; Song H; Liu S; Wang H; Wang M; Xiao H; Fu L; Fan Z; Bi Y; Yan J; Shi Y; Gao GF
    Cell Rep; 2019 Nov; 29(8):2217-2228.e5. PubMed ID: 31747596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options.
    Josset L; Zeng H; Kelly SM; Tumpey TM; Katze MG
    mBio; 2014 Feb; 5(1):e01102-13. PubMed ID: 24496798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple amino acid substitutions involved in the adaption of three avian-origin H7N9 influenza viruses in mice.
    Qin J; Peng O; Shen X; Gong L; Xue C; Cao Y
    Virol J; 2019 Jan; 16(1):3. PubMed ID: 30621708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil.
    Taniguchi K; Ando Y; Nobori H; Toba S; Noshi T; Kobayashi M; Kawai M; Yoshida R; Sato A; Shishido T; Naito A; Matsuno K; Okamatsu M; Sakoda Y; Kida H
    Sci Rep; 2019 Mar; 9(1):3466. PubMed ID: 30837531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammalian Pathogenesis and Transmission of Avian Influenza A(H7N9) Viruses, Tennessee, USA, 2017.
    Belser JA; Brock N; Sun X; Jones J; Zanders N; Hodges E; Pulit-Penaloza JA; Wentworth D; Tumpey TM; Davis T; Maines TR
    Emerg Infect Dis; 2018 Jan; 24(1):149-152. PubMed ID: 29260672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies.
    Kreijtz JH; Kroeze EJ; Stittelaar KJ; de Waal L; van Amerongen G; van Trierum S; van Run P; Bestebroer T; T Kuiken ; Fouchier RA; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2013 Oct; 31(43):4995-9. PubMed ID: 23816392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission and immunopathology of the avian influenza virus A/Anhui/1/2013 (H7N9) human isolate in three commonly commercialized avian species.
    Vidaña B; Dolz R; Busquets N; Ramis A; Sánchez R; Rivas R; Valle R; Cordón I; Solanes D; Martínez J; Majó N
    Zoonoses Public Health; 2018 May; 65(3):312-321. PubMed ID: 28905526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential responses of innate immunity triggered by different subtypes of influenza a viruses in human and avian hosts.
    Cao Y; Huang Y; Xu K; Liu Y; Li X; Xu Y; Zhong W; Hao P
    BMC Med Genomics; 2017 Dec; 10(Suppl 4):70. PubMed ID: 29322931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus subtype-specific suppression of MAVS aggregation and activation by PB1-F2 protein of influenza A (H7N9) virus.
    Cheung PH; Lee TT; Kew C; Chen H; Yuen KY; Chan CP; Jin DY
    PLoS Pathog; 2020 Jun; 16(6):e1008611. PubMed ID: 32511263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel human H7N9 influenza virus in China.
    Wang C; Luo J; Wang J; Su W; Gao S; Zhang M; Xie L; Ding H; Liu S; Liu X; Chen Y; Jia Y; He H
    Integr Zool; 2014 Jun; 9(3):372-5. PubMed ID: 24952971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Polymerase Activity Attributed to PA Drives the Acquisition of the PB2 E627K Mutation of H7N9 Avian Influenza Virus in Mammals.
    Liang L; Jiang L; Li J; Zhao Q; Wang J; He X; Huang S; Wang Q; Zhao Y; Wang G; Sun N; Deng G; Shi J; Tian G; Zeng X; Jiang Y; Liu L; Liu J; Chen P; Bu Z; Kawaoka Y; Chen H; Li C
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.
    Leung HC; Chan CC; Poon VK; Zhao HJ; Cheung CY; Ng F; Huang JD; Zheng BJ
    Emerg Microbes Infect; 2015 Apr; 4(4):e22. PubMed ID: 26038770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.